FDA Orange Book · active-ingredient family
Sodium nitrite
Sodium nitrite is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:SODIUM NITRITE · NDA 203922
1
Brand (NDA)
0
Generics (ANDA)
2
Listed patents
0
Exclusivity periods
Brand (NDA) products · solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SODIUM NITRITERLD | HOPE PHARMS | NDA 203922 | — | Feb 14, 2012 |
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9687506 | Feb 10, 2030 | in 3 yr 8 mo | ProductU-3394 |
| 8568793 | Dec 24, 2031 | in 5 yr 7 mo | SubstanceProduct |
Sodium nitrite — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

